Patients with hyperglycemia tend to be susceptible to Coronavirus disease 2019 (COVID-19). However, the association of HbA1c level with outcome of COVID-19 patients was unclear. We performed a retrospective study of 2880 cases of COVID-19 admitted in Tongji Hospital, Wuhan, China, among which 922 had detected the HbA1c levels. We found that COVID-19 patients with either lower levels of HbAlc (3%-4.9%) or higher levels of HbAlc (≥6%) were associated with elevated all-cause mortality. Meanwhile, we observed that HbAlc levels were highly correlated with haemoglobin (Hb) and total cholesterol (TC) (P < <
CITATION STYLE
Yuan, S., Li, H., Chen, C., Wang, F., & Wang, D. W. (2021). Association of glycosylated haemoglobin HbA1c levels with outcome in patients with COVID-19: A Retrospective Study. Journal of Cellular and Molecular Medicine, 25(7), 3484–3497. https://doi.org/10.1111/jcmm.16431
Mendeley helps you to discover research relevant for your work.